Future Directions in Cancer Research: Impact of the Completion of the Human Genome

Toxicologic Pathology

Volumn 32, Issue SUPPL. 1, 2004, Pages 1-2

  Zoon, Kathryn C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Bldg 31A ^*  (United States)

Author keywords

Gene expression profiling; Genomics; Proteomics; Regulatory approaches; Toxicity assessment

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; DRUG DEVELOPMENT; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENOMICS; GOVERNMENT REGULATION; HUMAN; MEDICAL GENETICS; MEDICAL INFORMATICS; MEDICAL TECHNOLOGY; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROTEOMICS; TOXICITY TESTING;

EID: 1842510725     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490424987     Document Type: Article

References (4)

1. Ahram, M., Best, C., Flaig, M., Gillespie, J., Leiva, I., Chaqui, R., Zhou, G., Shu, H., Duray, P., Linehan, W., Raffeld, M., Ornstein, D., Zhao, Y., Petricoin, E., and Emmert-Buck, M. (2002). Proteomic analysis of human prostate cancer. Mol Carcinog 33, 9-15.
2. Petricoin, E., Ardekani, A., Hitt, B., Levine, P., Fusaro, V., Steinberg, S., Mills, G., Simone, C. Fishman, D., Kohn, E., and Liotta, L. (2002a). Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-7.
3. Petricoin, E., Hackett, J., Lesko, L., Puri, R., Gutman, S., Chumakov, K., Woodcock, J., Feigal, D., Zoon, K. and Sistare, F. (2002b). Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 32, 474-9.
4. Wright, G., Tan, B., Rosenwald, A., Hurt, E., Wiestner, A., and Staudt, L. (2003). A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100, 9991-6.